Ignite Creation Date:
2024-05-06 @ 12:28 AM
Last Modification Date:
2024-10-26 @ 10:50 AM
Study NCT ID:
NCT01584440
Status:
COMPLETED
Last Update Posted:
2021-11-26
First Post:
2012-04-23
Brief Title:
Efficacy Safety and Tolerability Study of AVP-923 DextromethorphanQuinidine for Treatment of Symptoms of Agitation in Participants With Alzheimers Disease
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2014-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-23
First Submit QC Date:
April 24 2012
Study First Post Date:
2012-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-11-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2018-01-08
Disp First Submit QC Date:
January 8 2018
Disp First Post Date:
2018-01-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-29
Last Update Post Date:
2021-11-26
Last Update Post Date Type:
ACTUAL